Amp Capital Investors LTD Catalyst Pharmaceuticals, Inc. Transaction History

Amp Capital Investors LTD

  • $0
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$3.45 - $4.69 $245,815 - $334,167
-71,251 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$2.97 - $3.83 $42,286 - $54,531
-14,238 Reduced 16.65%
71,251 $244,000
Q1 2020

May 13, 2020
BUY
$2.61 - $5.21 $166,196 - $331,757
63,677 Added 291.94%
85,489 $331,000
Q4 2019

Feb 13, 2020
BUY
$3.67 - $5.7 $80,050 - $124,328
21,812 New
21,812 $80,000

Others Institutions Holding CPRX

# of Institutions
327
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.21B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email